Cystathionine ?-synthase mutations in homocystinuria

Jan P. Kraus(University of Colorado Denver), Miroslav Jano �k(Charles University), Viktor Ko ich(Charles University), Roseann Mandell(Harvard University), Vivian Shih(Harvard University), Maria Pia Sperandeo(Federico II University Hospital), Gianfranco Sebastio(Federico II University Hospital), R. de Franchis(Federico II University Hospital), Generoso Andria(Federico II University Hospital), Leo A. J. Kluijtmans(Radboud University Nijmegen), Henk J. Blom(Radboud University Nijmegen), Godfried H.J. Boers(Radboud University Nijmegen), Ross B. Gordon(Princess Alexandra Hospital), P. Kamoun(Hôpital Necker-Enfants Malades), Michael Y. Tsai(University of Minnesota Medical Center), Warren D. Kruger(Fox Chase Cancer Center), Hans Georg Koch(Zentrum für Kinderheilkunde), Toshihiro Ohura(Tohoku University), Mette Gaustadnes(Aarhus University Hospital)
Cited by 279

Abstract

The major cause of homocystinuria is mutation of the gene encoding the enzyme cystathionine beta-synthase (CBS). Deficiency of CBS activity results in elevated levels of homocysteine as well as methionine in plasma and urine and decreased levels of cystathionine and cysteine. Ninety-two different disease-associated mutations have been identified in the CBS gene in 310 examined homocystinuric alleles in more than a dozen laboratories around the world. Most of these mutations are missense, and the vast majority of these are private mutations. The two most frequently encountered of these mutations are the pyridoxine-responsive I278T and the pyridoxine-nonresponsive G307S. Mutations due to deaminations of methylcytosines represent 53% of all point substitutions in the coding region of the CBS gene.


Related Papers

No related papers found

Powered by citation graph analysis